This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hall, E. D. Articles by Braughler, J. M. Search for Related Content PubMed PubMed Citation Articles by Hall, E. D. Articles by Braughler, J. M.

Stroke, Vol 19, 997-1002, Copyright © 1988 by American Heart Association

ARTICLES

21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils

ED Hall, KE Pazara and JM Braughler
Central Nervous System Disease Research Unit, Upjohn Company, Kalamazoo, Michigan 49001.

U74006F (21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]-16 alpha-methylpregna-1,4,9(11)-triene-3,20-dione, monomethane sulfonate) is a novel and potent inhibitor of central nervous system tissue lipid peroxidation that is devoid of classical steroid hormonal activities. Its possible efficacy in attenuating postischemic mortality and neuronal necrosis was examined in gerbils following 3-hour unilateral carotid artery occlusion. Male Mongolian gerbils received two intraperitoneal injections of either vehicle or U74006F (3 or 10 mg/kg), the first injection 10 minutes before and the second injection at the end of the 3-hour ischemic episode. In an initial series of experiments, vehicle-treated gerbils displayed 60.9% (14 of 23) survival 24 hours after ischemia, which decreased to 34.8% (8 of 23) at 48 hours. In contrast, the 10 mg/kg U74006F-treated group showed 86.7% (13 of 15) survival at 24 hours (p less than 0.15 vs. vehicle) and 80.0% (12 of 15) survival at 48 hours (p less than 0.02). In a second series, neurons in the hippocampal CA1 subfield and the medial and lateral cerebral cortex were counted in gerbils surviving 24 hours after unilateral carotid artery occlusion. Comparison of neuronal densities in the ischemic hemisphere with those in the contralateral nonischemic hemisphere revealed significant neuronal preservation in all three brain regions of 10 mg/kg i.p. x 2 U74006F-treated gerbils. Our results show that U74006F can improve survival and attenuate neuronal necrosis in a severe brain ischemia model.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				Y. Gilgun-Sherki, Z. Rosenbaum, E. Melamed, and D. Offen Antioxidant Therapy in Acute Central Nervous System Injury: Current State Pharmacol. Rev., June 1, 2002; 54(2): 271 - 284. [Abstract] [Full Text] [PDF]

				H. B. van der Worp, L. J. Kappelle, A. Algra, P. R. Bar, J. M. Orgogozo, E. B. Ringelstein, P. M.W. Bath, and J. van Gijn The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke Neurology, January 8, 2002; 58(1): 133 - 135. [Abstract] [Full Text] [PDF]

				Y. Numagami and S. T. Ohnishi S-Allylcysteine Inhibits Free Radical Production, Lipid Peroxidation and Neuronal Damage in Rat Brain Ischemia J. Nutr., March 1, 2001; 131(3): 1100S - 1105. [Abstract] [Full Text]

				R. J. Kavanagh and P. C. A. Kam Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in neuroprotection Br. J. Anaesth., January 1, 2001; 86(1): 110 - 119. [Abstract] [Full Text] [PDF]

				Tirilazad Mesylate in Acute Ischemic Stroke : A Systematic Review Stroke, September 1, 2000; 31(9): 2257 - 2265. [Abstract] [Full Text] [PDF]

				L. C. Wienkers, R. C. Steenwyk, M. J. Hauer, J. C. Fleishaker, and P. G. Pearson Biotransformation of Tirilazad in Human: 3. Tirilazad A-Ring Reduction by Human Liver Microsomal 5alpha -Reductase Type 1 and Type 2 J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 583 - 590. [Abstract] [Full Text]

				H. B. van der Worp, P.R. Bar, L. J. Kappelle, D. J. de Wildt, and W. I. Rosenblum Dietary Vitamin E Levels Affect Outcome of Permanent Focal Cerebral Ischemia in Rats • Editorial Comment Stroke, May 1, 1998; 29(5): 1002 - 1006. [Abstract] [Full Text] [PDF]

				R. F. Villa and A. Gorini Pharmacology of Lazaroids and Brain Energy Metabolism: A Review Pharmacol. Rev., March 1, 1997; 49(1): 99 - 136. [Abstract] [Full Text] [PDF]

				H. Kim, R. C. Koehler, P. D. Hurn, E. D. Hall, and R. J. Traystman Amelioration of Impaired Cerebral Metabolism After Severe Acidotic Ischemia by Tirilazad Posttreatment in Dogs Stroke, January 1, 1996; 27(1): 114 - 121. [Abstract] [Full Text]

				J. C Grotta Prevention and management of stroke Vascular Medicine, March 1, 1991; 2(1): 3 - 17. [PDF]